Back to Newsroom

Cellular Dynamics Awarded Patents Covering Derivation of Pluripotent Stem Cells From Fresh or Banked Human Blood Samples

MADISON, Wis., July 9, 2014 (GLOBE NEWSWIRE) — Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that the U.S. Patent and Trademark Office (PTO) awarded the company three patents on the reprogramming of human cells into pluripotent stem cells from human blood. Joining an IP portfolio of over 800 patents awarded to or in-licensed by CDI, these patents position the company as the leading supplier of choice for a reliable, high quality supply of human cells for research, stem cell banking, and cellular therapy development.

Click here to read more